BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mukhopadhyay S, Vander Heiden MG, McCormick F. The Metabolic Landscape of RAS-Driven Cancers from biology to therapy. Nat Cancer 2021;2:271-83. [PMID: 33870211 DOI: 10.1038/s43018-021-00184-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Cao B, Deng H, Cui H, Zhao R, Li H, Wei B, Chen L. Knockdown of PGM1 enhances anticancer effects of orlistat in gastric cancer under glucose deprivation. Cancer Cell Int 2021;21:481. [PMID: 34507580 DOI: 10.1186/s12935-021-02193-3] [Reference Citation Analysis]
2 Jacobs F, Cani M, Malapelle U, Novello S, Napoli VM, Bironzo P. Targeting KRAS in NSCLC: Old Failures and New Options for "Non-G12c" Patients. Cancers (Basel) 2021;13:6332. [PMID: 34944952 DOI: 10.3390/cancers13246332] [Reference Citation Analysis]
3 Bansod S, Dodhiawala PB, Lim KH. Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities. Cancers (Basel) 2021;13:5481. [PMID: 34771644 DOI: 10.3390/cancers13215481] [Reference Citation Analysis]
4 Nassif RM, Chalhoub E, Chedid P, Hurtado-nedelec M, Raya E, Dang PM, Marie J, El-benna J. Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK. Biomedicines 2022;10:319. [DOI: 10.3390/biomedicines10020319] [Reference Citation Analysis]
5 Cuesta C, Arévalo-Alameda C, Castellano E. The Importance of Being PI3K in the RAS Signaling Network. Genes (Basel) 2021;12:1094. [PMID: 34356110 DOI: 10.3390/genes12071094] [Reference Citation Analysis]
6 Adachi Y, Kimura R, Hirade K, Ebi H. Escaping KRAS: Gaining Autonomy and Resistance to KRAS Inhibition in KRAS Mutant Cancers. Cancers (Basel) 2021;13:5081. [PMID: 34680229 DOI: 10.3390/cancers13205081] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rahman S, Garrel S, Gerber M, Maitra R, Goel S. Therapeutic Targets of KRAS in Colorectal Cancer. Cancers (Basel) 2021;13:6233. [PMID: 34944853 DOI: 10.3390/cancers13246233] [Reference Citation Analysis]
8 Zhu L, Miao B, Dymerska D, Kuswik M, Bueno-martínez E, Sanoguera-miralles L, Velasco EA, Paramasivam N, Schlesner M, Kumar A, Yuan Y, Lubinski J, Bandapalli OR, Hemminki K, Försti A. Germline Variants of CYBA and TRPM4 Predispose to Familial Colorectal Cancer. Cancers 2022;14:670. [DOI: 10.3390/cancers14030670] [Reference Citation Analysis]
9 Haidar M, Jacquemin P. Past and Future Strategies to Inhibit Membrane Localization of the KRAS Oncogene. Int J Mol Sci 2021;22:13193. [PMID: 34947990 DOI: 10.3390/ijms222413193] [Reference Citation Analysis]
10 Tambay V, Raymond VA, Bilodeau M. MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype. Cancers (Basel) 2021;13:4484. [PMID: 34503295 DOI: 10.3390/cancers13174484] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ghomlaghi M, Hart A, Hoang N, Shin S, Nguyen LK. Feedback, Crosstalk and Competition: Ingredients for Emergent Non-Linear Behaviour in the PI3K/mTOR Signalling Network. Int J Mol Sci 2021;22:6944. [PMID: 34203293 DOI: 10.3390/ijms22136944] [Reference Citation Analysis]
12 Liu Y, Yu H, Guo Y, Huang D, Liu J, Pan M, Wang L, Zhang W, Mai K. Arginine Regulates TOR Signaling Pathway through SLC38A9 in Abalone Haliotis discus hannai. Cells 2021;10:2552. [PMID: 34685533 DOI: 10.3390/cells10102552] [Reference Citation Analysis]
13 Rio-Vilariño A, Del Puerto-Nevado L, García-Foncillas J, Cebrián A. Ras Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance. Cancers (Basel) 2021;13:3757. [PMID: 34359657 DOI: 10.3390/cancers13153757] [Reference Citation Analysis]
14 Lee JJ, Jain V, Amaravadi RK. Clinical Translation of Combined MAPK and Autophagy Inhibition in RAS Mutant Cancer. Int J Mol Sci 2021;22:12402. [PMID: 34830283 DOI: 10.3390/ijms222212402] [Reference Citation Analysis]
15 Takacova M, Kajanova I, Kolarcikova M, Lapinova J, Zatovicova M, Pastorekova S. Understanding metabolic alterations and heterogeneity in cancer progression through validated immunodetection of key molecular components: a case of carbonic anhydrase IX. Cancer Metastasis Rev 2022. [PMID: 35080763 DOI: 10.1007/s10555-021-10011-5] [Reference Citation Analysis]
16 Yu F, Gajendran B, Wang N, Sample KM, Liu W, Wang C, Hu A, Zacksenhaus E, Hao X, Ben-David Y. ERK activation via A1542/3 limonoids attenuates erythroleukemia through transcriptional stimulation of cholesterol biosynthesis genes. BMC Cancer 2021;21:680. [PMID: 34107900 DOI: 10.1186/s12885-021-08402-6] [Reference Citation Analysis]
17 Kubicka A, Matczak K, Łabieniec-Watała M. More Than Meets the Eye Regarding Cancer Metabolism. Int J Mol Sci 2021;22:9507. [PMID: 34502416 DOI: 10.3390/ijms22179507] [Reference Citation Analysis]
18 Vivet-noguer R, Tarin M, Canbezdi C, Dayot S, Silva L, Houy A, Martineau S, Mieulet V, Gentric G, Loew D, Lombard B, Nemati F, Richon S, Guyonnet L, Servois V, Vagner S, Stern M, Roman-roman S, Alsafadi S. Glycolysis Dependency as a Hallmark of SF3B1-Mutated Cells. Cancers 2022;14:2113. [DOI: 10.3390/cancers14092113] [Reference Citation Analysis]
19 Schwab M, Thunborg K, Azimzadeh O, von Toerne C, Werner C, Shevtsov M, Di Genio T, Zdralevic M, Pouyssegur J, Renner K, Kreutz M, Multhoff G. Targeting Cancer Metabolism Breaks Radioresistance by Impairing the Stress Response. Cancers (Basel) 2021;13:3762. [PMID: 34359663 DOI: 10.3390/cancers13153762] [Reference Citation Analysis]
20 Molina-Arcas M, Samani A, Downward J. Drugging the Undruggable: Advances on RAS Targeting in Cancer. Genes (Basel) 2021;12:899. [PMID: 34200676 DOI: 10.3390/genes12060899] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Sharifi-Rad J, Quispe C, Butnariu M, Rotariu LS, Sytar O, Sestito S, Rapposelli S, Akram M, Iqbal M, Krishna A, Kumar NVA, Braga SS, Cardoso SM, Jafernik K, Ekiert H, Cruz-Martins N, Szopa A, Villagran M, Mardones L, Martorell M, Docea AO, Calina D. Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment. Cancer Cell Int 2021;21:318. [PMID: 34167552 DOI: 10.1186/s12935-021-02025-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Yang J, Zhou Y, Xie S, Wang J, Li Z, Chen L, Mao M, Chen C, Huang A, Chen Y, Zhang X, Khan NUH, Wang L, Zhou J. Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. J Exp Clin Cancer Res 2021;40:206. [PMID: 34162423 DOI: 10.1186/s13046-021-02012-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Nie Q, Hu Y, Yu X, Li X, Fang X. Induction and application of ferroptosis in cancer therapy. Cancer Cell Int 2022;22:12. [PMID: 34996454 DOI: 10.1186/s12935-021-02366-0] [Reference Citation Analysis]